Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Diphenhydramine Treatment Report
What is Diphenhydramine?

Diphenhydramine is an antihistamine. It is used to relieve irritated, itchy, watery eyes; sneezing; and runny nose caused by hay fever, allergies, or the common cold. It may also be used to prevent and treat motion sickness, or to control abnormal movements in early stage parkinsonian syndrome.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Other 7 1
Excess saliva 2 0
Insomnia 2 0
disease-related symptoms 1 0
Hives 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
1 100%

Dosages

  25mg as needed 50mg as needed daily mg as needed 50 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2  

Stop Reasons

Why Patients Stopped Taking Diphenhydramine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other
5 71% Other: 71%
Doctor's advice
1 14% Doctor's advice: 14%
Course of treatment ended
1 14% Course of treatment ended: 14%

See all 7 patients who’ve stopped taking Diphenhydramine

Currently Taking Diphenhydramine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
1
1
3

Stopped Taking Diphenhydramine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
3
3
0
1

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
1 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
1 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
1 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.